Dishman Carbogen

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE385W01011
NSEID: DCAL
BSEID: 540701

INR

203.95

14.25 (7.51%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.41 lacs

{
  "main_header": {
    "sid": 1002833,
    "name": "Dishman Carbogen",
    "stock_name": "Dishman Carbogen",
    "full_name": "Dishman Carbogen Amcis Ltd",
    "name_url": "stocks-analysis/dishman-carbogen",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "203.95",
    "chg": 14.25,
    "chgp": "7.51%",
    "dir": 1,
    "prev_price": "189.70",
    "mcapval": "3,197.59 Cr",
    "mcap": "Small Cap",
    "scripcode": 540701,
    "symbol": "DCAL",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE385W01011",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:08 AM",
    "bse_nse_vol": "7.41 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dishman-carbogen-1002833-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dishman Carbogen Amcis Faces Mixed Technical Signals Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-mixed-indicators-1670946",
        "imagepath": "",
        "date": "2025-04-02 08:09:10",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 218.90, showing a slight increase from the previous close of 216.70. Over the past year, the stock has experienced a decline of 10.08%, contrasting with a 2.72% gain in the Sensex, highlighting a challenging performance relative to the broader market.\n\nIn terms of technical indicators, the weekly MACD and KST are showing bearish signals, while the daily moving averages indicate a mildly bullish trend. The Bollinger Bands present a mixed picture, with weekly readings leaning bearish and monthly readings indicating a sideways trend. The Relative Strength Index (RSI) remains neutral, suggesting a lack of strong momentum in either direction.\n\nLooking at the company's return compared to the Sensex, Dishman Carbog..."
      },
      {
        "title": "Dishman Carbogen Amcis Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-1424168",
        "imagepath": "",
        "date": "2025-03-18 08:03:58",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 212.35, showing a slight increase from the previous close of 208.80. Over the past year, the stock has experienced a decline of 4.82%, contrasting with a 2.10% gain in the Sensex during the same period.\n\nIn terms of technical indicators, the weekly MACD and Bollinger Bands suggest a mildly bearish outlook, while the monthly metrics indicate a bullish trend. The daily moving averages lean towards a mildly bullish stance, highlighting some positive momentum in the short term. However, the KST and OBV metrics present a mixed picture, with both weekly and monthly readings showing bearish tendencies.\n\nWhen comparing the stock's performance to the Sensex, Dishman Carbogen has shown a notable return of 24.73% over ..."
      },
      {
        "title": "Dishman Carbogen Amcis Faces Growth Challenges Amidst Debt Management Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dishman-carbogen-amcis-receives-sell-rating-amid-flat-financial-performance-and-high-debt-levels-1400705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DishmanCarbogen_mojoScore_681117.png",
        "date": "2025-03-17 10:24:54",
        "description": "Dishman Carbogen Amcis has recently experienced an evaluation adjustment amid flat financial performance for Q3 FY24-25. The company faces challenges in long-term growth, with a declining CAGR in operating profits and concerns over debt management. Institutional investors have increased their stake, indicating a potential shift in perception."
      },
      {
        "title": "Dishman Carbogen Amcis Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-price-decline-1397305",
        "imagepath": "",
        "date": "2025-03-17 08:01:25",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 208.80, slightly down from the previous close of 209.00. Over the past year, Dishman Carbogen has experienced a notable fluctuation, with a 52-week high of 307.80 and a low of 132.75.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on both weekly and monthly scales, while the Bollinger Bands reflect a bearish stance weekly and a sideways trend monthly. The daily moving averages suggest a mildly bullish outlook, contrasting with the overall mildly bearish signals from the KST and Dow Theory metrics.\n\nIn terms of returns, Dishman Carbogen has faced challenges compared to the Sensex. Over the past week, the stock returned -2.16%, while the Se..."
      },
      {
        "title": "Dishman Carbogen Faces Mixed Technical Trends Amid Market Volatility and Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-20-1371764",
        "imagepath": "",
        "date": "2025-03-13 08:02:29",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 209.00, down from a previous close of 213.25. Over the past year, the stock has experienced a high of 307.80 and a low of 132.75, indicating significant volatility.\n\nThe technical summary reveals a mixed picture, with various indicators showing differing trends. The MACD readings for both weekly and monthly periods are mildly bearish, while the moving averages on a daily basis suggest a mildly bullish stance. The Bollinger Bands indicate a bearish trend on a weekly basis but a bullish outlook on a monthly scale. Overall, the technical indicators present a complex landscape for the stock.\n\nIn terms of performance, Dishman Carbogen's returns have lagged behind the Sensex across multiple time frames. Over the pas..."
      },
      {
        "title": "Dishman Carbogen Faces Mixed Technical Trends Amid Market Volatility and Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-8-1344386",
        "imagepath": "",
        "date": "2025-03-13 08:02:29",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 209.00, down from a previous close of 213.25. Over the past year, the stock has experienced a high of 307.80 and a low of 132.75, indicating significant volatility.\n\nThe technical summary reveals a mixed picture, with various indicators showing differing trends. The MACD readings for both weekly and monthly periods are mildly bearish, while the moving averages on a daily basis suggest a mildly bullish stance. The Bollinger Bands indicate a bearish trend on a weekly basis but a bullish outlook on a monthly scale. Overall, the technical indicators present a complex landscape for the stock.\n\nIn terms of performance, Dishman Carbogen's returns have lagged behind the Sensex across multiple time frames. Over the pas..."
      },
      {
        "title": "Dishman Carbogen Amcis Shows Mixed Technical Trends Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-mildly-bearish-to-mildly-bullish-1378832",
        "imagepath": "",
        "date": "2025-03-12 08:03:04",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 213.25, showing a slight increase from the previous close of 208.85. Over the past year, the stock has experienced a high of 307.80 and a low of 132.75, indicating significant volatility.\n\nIn terms of technical indicators, the weekly MACD and KST suggest a mildly bearish sentiment, while the monthly MACD indicates a bullish trend. The Bollinger Bands present a mixed picture, with weekly readings showing bearish tendencies and monthly readings leaning bullish. Daily moving averages reflect a mildly bullish outlook, contributing to the overall technical summary.\n\nWhen comparing the stock's performance to the Sensex, Dishman Carbogen Amcis has shown varied returns. Over the past week, the stock returned 4.92%, si..."
      },
      {
        "title": "Dishman Carbogen Faces Financial Stability Amid Declining Profits and Rising Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dishman-carbogen-amcis-downgraded-to-strong-sell-amid-flat-financial-performance-1270394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DishmanCarbogen_mojoScore_637070.png",
        "date": "2025-03-11 08:17:10",
        "description": "Dishman Carbogen Amcis has recently adjusted its evaluation, reflecting a stable financial performance for Q3 FY24-25. However, the company faces challenges, including a significant decline in operating profits over five years and weak debt management, raising concerns about its long-term financial health. Institutional investors have slightly increased their stakes."
      },
      {
        "title": "Dishman Carbogen Amcis Faces Technical Trend Shifts Amid Mixed Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-technical-trend-shifts-from-mildly-bullish-to-mildly-bearish-amid-stock-price-decline-1277945",
        "imagepath": "",
        "date": "2025-03-11 08:04:53",
        "description": "Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting shifts in its technical indicators. The company's current price stands at 208.85, down from a previous close of 214.95, with a notable 52-week high of 307.80 and a low of 132.75. \n\nThe technical summary indicates a mildly bearish sentiment across various metrics. The MACD readings for both weekly and monthly periods suggest a bearish outlook, while the Bollinger Bands show a bearish trend on a weekly basis and a sideways movement monthly. The KST and Dow Theory also align with this bearish sentiment, indicating a cautious market stance. \n\nIn terms of performance, Dishman Carbogen's stock has shown mixed results compared to the Sensex. Over the past week, the stock returned 3.11%, outperforming the Sensex's 1.41%. However, on a monthly basis, it has underperformed with ..."
      }
    ],
    "total": 76,
    "sid": "1002833",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/dishman-carbogen-amcis-1002833"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2025",
      "details": "Pls. find enclosed herewith the certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    },
    {
      "caption": "DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015: COMPANYS WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS (SHANGHAI) CO. LTD. RECEIVED DRUG MANUFACTURING LICENSE FROM THE NATIONAL MEDICAL PRODUCT ADMINISTRATION FOR ITS SHANGHAI SI",
      "datetime": "09-Apr-2025",
      "details": "Pls. find attached herewith the disclosure under Regulations 30 and 51 of SEBI LODR.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "01-Apr-2025",
      "details": "Pls. find attached herewith the intimation of cessation and appointment of Independent Directors.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dishman Carbogen Amcis Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 19",
          "dt": "2019-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dishman Carbogen Amcis Faces Mixed Technical Signals Amid Market Challenges

2025-04-02 08:09:10

Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 218.90, showing a slight increase from the previous close of 216.70. Over the past year, the stock has experienced a decline of 10.08%, contrasting with a 2.72% gain in the Sensex, highlighting a challenging performance relative to the broader market. In terms of technical indicators, the weekly MACD and KST are showing bearish signals, while the daily moving averages indicate a mildly bullish trend. The Bollinger Bands present a mixed picture, with weekly readings leaning bearish and monthly readings indicating a sideways trend. The Relative Strength Index (RSI) remains neutral, suggesting a lack of strong momentum in either direction. Looking at the company's return compared to the Sensex, Dishman Carbog...

Dishman Carbogen Amcis Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-18 08:03:58

Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 212.35, showing a slight increase from the previous close of 208.80. Over the past year, the stock has experienced a decline of 4.82%, contrasting with a 2.10% gain in the Sensex during the same period. In terms of technical indicators, the weekly MACD and Bollinger Bands suggest a mildly bearish outlook, while the monthly metrics indicate a bullish trend. The daily moving averages lean towards a mildly bullish stance, highlighting some positive momentum in the short term. However, the KST and OBV metrics present a mixed picture, with both weekly and monthly readings showing bearish tendencies. When comparing the stock's performance to the Sensex, Dishman Carbogen has shown a notable return of 24.73% over ...

Dishman Carbogen Amcis Faces Growth Challenges Amidst Debt Management Concerns

2025-03-17 10:24:54

Dishman Carbogen Amcis has recently experienced an evaluation adjustment amid flat financial performance for Q3 FY24-25. The company faces challenges in long-term growth, with a declining CAGR in operating profits and concerns over debt management. Institutional investors have increased their stake, indicating a potential shift in perception.

Dishman Carbogen Amcis Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-17 08:01:25

Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 208.80, slightly down from the previous close of 209.00. Over the past year, Dishman Carbogen has experienced a notable fluctuation, with a 52-week high of 307.80 and a low of 132.75. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on both weekly and monthly scales, while the Bollinger Bands reflect a bearish stance weekly and a sideways trend monthly. The daily moving averages suggest a mildly bullish outlook, contrasting with the overall mildly bearish signals from the KST and Dow Theory metrics. In terms of returns, Dishman Carbogen has faced challenges compared to the Sensex. Over the past week, the stock returned -2.16%, while the Se...

Dishman Carbogen Faces Mixed Technical Trends Amid Market Volatility and Underperformance

2025-03-13 08:02:29

Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 209.00, down from a previous close of 213.25. Over the past year, the stock has experienced a high of 307.80 and a low of 132.75, indicating significant volatility. The technical summary reveals a mixed picture, with various indicators showing differing trends. The MACD readings for both weekly and monthly periods are mildly bearish, while the moving averages on a daily basis suggest a mildly bullish stance. The Bollinger Bands indicate a bearish trend on a weekly basis but a bullish outlook on a monthly scale. Overall, the technical indicators present a complex landscape for the stock. In terms of performance, Dishman Carbogen's returns have lagged behind the Sensex across multiple time frames. Over the pas...

Dishman Carbogen Faces Mixed Technical Trends Amid Market Volatility and Underperformance

2025-03-13 08:02:29

Dishman Carbogen Amcis Shows Mixed Technical Trends Amid Market Volatility

2025-03-12 08:03:04

Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 213.25, showing a slight increase from the previous close of 208.85. Over the past year, the stock has experienced a high of 307.80 and a low of 132.75, indicating significant volatility. In terms of technical indicators, the weekly MACD and KST suggest a mildly bearish sentiment, while the monthly MACD indicates a bullish trend. The Bollinger Bands present a mixed picture, with weekly readings showing bearish tendencies and monthly readings leaning bullish. Daily moving averages reflect a mildly bullish outlook, contributing to the overall technical summary. When comparing the stock's performance to the Sensex, Dishman Carbogen Amcis has shown varied returns. Over the past week, the stock returned 4.92%, si...

Dishman Carbogen Faces Financial Stability Amid Declining Profits and Rising Debt Concerns

2025-03-11 08:17:10

Dishman Carbogen Amcis has recently adjusted its evaluation, reflecting a stable financial performance for Q3 FY24-25. However, the company faces challenges, including a significant decline in operating profits over five years and weak debt management, raising concerns about its long-term financial health. Institutional investors have slightly increased their stakes.

Dishman Carbogen Amcis Faces Technical Trend Shifts Amid Mixed Performance Metrics

2025-03-11 08:04:53

Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting shifts in its technical indicators. The company's current price stands at 208.85, down from a previous close of 214.95, with a notable 52-week high of 307.80 and a low of 132.75. The technical summary indicates a mildly bearish sentiment across various metrics. The MACD readings for both weekly and monthly periods suggest a bearish outlook, while the Bollinger Bands show a bearish trend on a weekly basis and a sideways movement monthly. The KST and Dow Theory also align with this bearish sentiment, indicating a cautious market stance. In terms of performance, Dishman Carbogen's stock has shown mixed results compared to the Sensex. Over the past week, the stock returned 3.11%, outperforming the Sensex's 1.41%. However, on a monthly basis, it has underperformed with ...

View All News